Delivery Order SPE2DB20D7061-SPE2DB25FSPW6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,436.38 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $37,169.95 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 10, 2025, with completion targeted for September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 19, 2025, for supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $62,283.78 and firm fixed pricing. This non-set-aside, competitively awarded contract is scheduled for completion by August 20, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under the company's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $17,313.29. The order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $13,457.37 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on August 14, 2025, with completion expected by August 15, 2025. This firm fixed price contract represents a non-set-aside competitive award, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $76,344.15 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order represents a non-competitive award and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $12,257.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). The contract was competitively awarded without set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $13,924.72. The award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPW6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,965.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count package. Issued on September 18, 2025, with an ultimate completion date of September 19, 2025, this firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management pharmaceuticals, and specialized medical supplies. This particular delivery order for Jardiance—a diabetes medication—exemplifies the routine pharmaceutical supply operations conducted through the company's prime vendor agreement with the Defense Logistics Agency, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 9/18/25 |